{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-082149","form_type":"8-K/A","ticker":"WHWK","cik":"0001422142","company_name":"Whitehawk Therapeutics, Inc.","filed_at":"2023-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.871656+00:00","generated_at":"2026-06-17T12:33:14.323617+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Aadi Bioscience discloses compensation for interim CEO Scott Giacobello: quarterly bonus, option grant","bullets":["Scott Giacobello appointed Interim CEO and President effective March 15, 2023; remains CFO.","Quarterly bonus of $43,000 (prorated) approved for interim role.","Eligible for annual cash bonus at 90% of base salary based on performance objectives.","Received stock option for 100,000 shares vesting over 4 years with standard schedule."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-082149","json":"https://secwatch.observer/filing/0001193125-23-082149.json","markdown":"https://secwatch.observer/filing/0001193125-23-082149.md","text":"https://secwatch.observer/filing/0001193125-23-082149.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422142/000119312523082149/0001193125-23-082149-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422142/000119312523082149/d492554d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T12:33:14.323617+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aa0fa9cc37","claim":"Scott Giacobello was appointed as Interim Chief Executive Officer and President at Whitehawk Therapeutics, Inc..","evidence_excerpt":"appointed Scott Giacobello as the Company’s Interim Chief Executive Officer and President, effective March 15, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422142/000119312523082149/0001193125-23-082149-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer and President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}